Trial Profile
The effect of ticagrelor on the QT interval in male volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Moxifloxacin
- Indications Acute coronary syndromes; Bacterial infections; Embolism and thrombosis
- Focus Adverse reactions
- Sponsors AstraZeneca
- 05 Nov 2010 New trial record.